Cardinal Health/$CAH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cardinal Health
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Ticker
$CAH
Sector
Primary listing
NYSE
Employees
55,392
Headquarters
Website
Cardinal Health Metrics
BasicAdvanced
$37B
24.25
$6.45
0.72
$2.03
1.31%
Price and volume
Market cap
$37B
Beta
0.72
52-week high
$168.44
52-week low
$106.98
Average daily volume
2.3M
Dividend rate
$2.03
Financial strength
Current ratio
0.935
Quick ratio
0.44
Long term debt to equity
-302.847
Total debt to equity
-356.416
Dividend payout ratio (TTM)
31.65%
Interest coverage (TTM)
10.80%
Profitability
EBITDA (TTM)
3,273
Gross margin (TTM)
3.67%
Net profit margin (TTM)
0.70%
Operating margin (TTM)
1.12%
Effective tax rate (TTM)
25.32%
Revenue per employee (TTM)
$4,020,000
Management effectiveness
Return on assets (TTM)
3.16%
Return on equity (TTM)
-53.68%
Valuation
Price to earnings (TTM)
24.25
Price to revenue (TTM)
0.169
Price to book
-14.19
Price to tangible book (TTM)
-2.5
Price to free cash flow (TTM)
20.376
Free cash flow yield (TTM)
4.91%
Free cash flow per share (TTM)
7.676
Dividend yield (TTM)
1.30%
Forward dividend yield
1.31%
Growth
Revenue change (TTM)
-1.87%
Earnings per share change (TTM)
86.96%
3-year revenue growth (CAGR)
7.07%
10-year revenue growth (CAGR)
8.06%
3-year earnings per share growth (CAGR)
24.16%
10-year earnings per share growth (CAGR)
5.95%
3-year dividend per share growth (CAGR)
1.00%
10-year dividend per share growth (CAGR)
3.67%
What the Analysts think about Cardinal Health
Analyst ratings (Buy, Hold, Sell) for Cardinal Health stock.
Bulls say / Bears say
On August 12, 2025, Cardinal Health raised its fiscal 2026 non-GAAP EPS guidance to $9.30–$9.50, up from $9.10–$9.30, signaling management’s confidence in sustained earnings growth (Reuters)
Cardinal Health plans to open a new automated drug distribution facility in Indianapolis, incorporating advanced robotics to streamline specialty medication logistics and bolster its national supply network by fall 2027 (Reuters)
According to the Wall Street Journal, Cardinal Health added over $10 billion in new business in the past fiscal year and now manages over 70,000 drug deliveries daily, underscoring robust network expansion and volume growth (WSJ)
Q4 FY25 revenue of $60.16 billion came in just under expectations, weighed by the expiration of a key OptumRx contract and reflecting vulnerability from customer concentration (Reuters)
On October 3, 2025, CAH shares slid 2.52% to $154.46, underperforming the S&P 500 and closing 8.3% below its 52-week high, signaling waning investor confidence in the stock’s momentum (MarketWatch)
The stock plunged 10% in a single session following mixed Q4 results and the announcement of the Solaris Health acquisition, marking its worst daily drop since 2021 and underscoring skepticism over growth strategy execution (Barron’s)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Cardinal Health Financial Performance
Revenues and expenses
Cardinal Health Earnings Performance
Company profitability
Cardinal Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cardinal Health stock?
Cardinal Health (CAH) has a market cap of $37B as of October 19, 2025.
What is the P/E ratio for Cardinal Health stock?
The price to earnings (P/E) ratio for Cardinal Health (CAH) stock is 24.25 as of October 19, 2025.
Does Cardinal Health stock pay dividends?
Yes, the Cardinal Health (CAH) stock pays dividends to shareholders. As of October 19, 2025, the dividend rate is $2.0326 and the yield is 1.31%. Cardinal Health has a payout ratio of 31.65% on a trailing twelve-month basis.
When is the next Cardinal Health dividend payment date?
The next Cardinal Health (CAH) dividend payment date is unconfirmed.
What is the beta indicator for Cardinal Health?
Cardinal Health (CAH) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.